KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Other Non Operating Income (2017 - 2021)

Historic Other Non Operating Income for Elevance Health (ELV) over the last 8 years, with Q4 2021 value amounting to -$16.0 million.

  • Elevance Health's Other Non Operating Income fell 70000.0% to -$16.0 million in Q4 2021 from the same period last year, while for Dec 2022 it was -$16.0 million, marking a year-over-year increase of 2380.95%. This contributed to the annual value of -$21.0 million for FY2021, which is 4166.67% up from last year.
  • According to the latest figures from Q4 2021, Elevance Health's Other Non Operating Income is -$16.0 million, which was down 70000.0% from -$5.0 million recorded in Q2 2021.
  • Elevance Health's 5-year Other Non Operating Income high stood at $6.0 million for Q4 2018, and its period low was -$282.0 million during Q4 2017.
  • In the last 5 years, Elevance Health's Other Non Operating Income had a median value of -$3.0 million in 2019 and averaged -$27.0 million.
  • In the last 5 years, Elevance Health's Other Non Operating Income surged by 10555.56% in 2019 and then crashed by 70000.0% in 2021.
  • Quarter analysis of 5 years shows Elevance Health's Other Non Operating Income stood at -$282.0 million in 2017, then soared by 102.13% to $6.0 million in 2018, then plummeted by 150.0% to -$3.0 million in 2019, then surged by 33.33% to -$2.0 million in 2020, then tumbled by 700.0% to -$16.0 million in 2021.
  • Its Other Non Operating Income stands at -$16.0 million for Q4 2021, versus -$5.0 million for Q2 2021 and -$2.0 million for Q4 2020.